Arkolith/Insider Trading/CRBU/Form 4

McClung Barbara G

Chief Legal OfficerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Feb 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2025Sell(S)4K$1.35$5K444K
Feb 20, 2025Grant(A)38K—$0447K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2025Grant(A)170K—$0170K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231321-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML